← All sources
Intermittent fasting and human metabolic health
Comprehensive review of human studies on intermittent fasting, demonstrating improvements in insulin sensitivity, lipid profiles, and inflammatory markers.
Metabolic Benefits
- Fasting insulin reduction: 20-31%
- LDL cholesterol reduction: 5-15%
- CRP reduction: 5-40%
Time-Restricted Eating
8-10 hour eating windows show most consistent benefits in human trials.
Outcomes
- Fasting Insulin-25.5
- Systolic Blood Pressure-2.8mmHg (Millimetres of Mercury)
- C-Reactive Protein-22.5